Funding for this research was provided by:
Chemie-Wirtschaftsförderungsgesellschaft mbH
Friedrich-Alexander-Universität Erlangen-Nürnberg
Article History
Received: 16 April 2021
Accepted: 15 June 2021
First Online: 27 June 2021
Declarations
:
: H. Denghel, J. Hiller and T. Göen declare no conflict of interest. E. Leibold is employed by BASF. BASF is a producer of UV 328.
: The study participants gave their written informed consent to their study participation. The study has been approved by the ethics committee of the medical faculty of the Friedrich-Alexander-University Erlangen-Nuremberg and has been performed in accordance with the ethical standards (No. 15_16 B).